PMID- 24531690 OWN - NLM STAT- MEDLINE DCOM- 20140819 LR - 20211021 IS - 1523-1747 (Electronic) IS - 0022-202X (Linking) VI - 134 IP - 7 DP - 2014 Jul TI - Nonmetal haptens induce ATP release from keratinocytes through opening of pannexin hemichannels by reactive oxygen species. PG - 1951-1960 LID - S0022-202X(15)36869-X [pii] LID - 10.1038/jid.2014.93 [doi] AB - Although extracellular adenosine 5'-triphosphate (eATP) has a crucial role in the sensitization phase of contact hypersensitivity (CHS), the mechanism by which hapten causes keratinocyte cell death and ATP release is unknown. We examined the time course of cell death, reactive oxygen species (ROS) production, and ATP release in HaCaT cells and in normal human keratinocytes after exposure to nonmetal haptens, NiCl2, or irritants. Both haptens and irritants caused cell death of keratinocytes but with different time courses. N-acetylcysteine (NAC) significantly reduced only nonmetal hapten-induced cell death as assessed by propidium iodide exclusion. We examined the effects of antioxidants and pannexin (Panx) inhibitors on cell death, ROS production, and ATP release by chemical-treated HaCaT cells. Nonmetal hapten-induced cell death, but not NiCl2- or irritant-related cell death, was dependent on reactivity to thiol residues in the cells. NAC reduced cell death and ATP release, whereas antioxidants and Panx inhibitors did not inhibit cell death but significantly attenuated ATP release. Panx1 small interfering RNA (siRNA) also suppressed ATP release from hapten-exposed HaCaT cells. Intraperitoneal injection of a Panx1 inhibitor attenuated murine CHS. These findings suggest that nonmetal hapten reactivity to thiol residues causes membrane disruption of keratinocytes and ROS production that leads to ATP release through opening of Panx hemichannels. FAU - Onami, Kaoru AU - Onami K AD - Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. FAU - Kimura, Yutaka AU - Kimura Y AD - Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. FAU - Ito, Yumiko AU - Ito Y AD - Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. FAU - Yamauchi, Takeshi AU - Yamauchi T AD - Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. FAU - Yamasaki, Kenshi AU - Yamasaki K AD - Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. FAU - Aiba, Setsuya AU - Aiba S AD - Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: saiba@med.tohoku.ac.jp. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140214 PL - United States TA - J Invest Dermatol JT - The Journal of investigative dermatology JID - 0426720 RN - 0 ((1,5-dihydro-5-(5-pyrimidine-2,4(1H,3H)-dionyl)-2H-chromeno(2,3-d)pyrimidine-2,4(3H)-dione)) RN - 0 (Antioxidants) RN - 0 (Benzopyrans) RN - 0 (Connexins) RN - 0 (Dinitrochlorobenzene) RN - 0 (Haptens) RN - 0 (Irritants) RN - 0 (Nerve Tissue Proteins) RN - 0 (PANX1 protein, human) RN - 0 (Pyrimidinones) RN - 0 (RNA, Small Interfering) RN - 0 (Reactive Oxygen Species) RN - 48TCX9A1VT (Cystine) RN - 696BNE976J (nickel chloride) RN - 7OV03QG267 (Nickel) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - YXO5V2CF3F (N-monoacetylcystine) SB - IM MH - Adenosine Triphosphate/*metabolism MH - Animals MH - Antioxidants/pharmacology MH - Benzopyrans/pharmacology MH - Cell Death/drug effects/physiology MH - Cells, Cultured MH - Connexins/chemistry/genetics/*metabolism MH - Cystine/analogs & derivatives/pharmacology MH - Dermatitis, Contact/*metabolism/pathology MH - Dinitrochlorobenzene/pharmacology MH - Disease Models, Animal MH - Female MH - Haptens/*metabolism MH - Humans MH - Irritants/pharmacology MH - Keratinocytes/cytology/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - Nerve Tissue Proteins/chemistry/genetics/*metabolism MH - Nickel/pharmacology MH - Protein Structure, Quaternary MH - Protein Structure, Tertiary MH - Pyrimidinones/pharmacology MH - RNA, Small Interfering/genetics MH - Reactive Oxygen Species/*metabolism EDAT- 2014/02/18 06:00 MHDA- 2014/08/20 06:00 CRDT- 2014/02/18 06:00 PHST- 2013/09/26 00:00 [received] PHST- 2014/01/30 00:00 [revised] PHST- 2014/02/03 00:00 [accepted] PHST- 2014/02/18 06:00 [entrez] PHST- 2014/02/18 06:00 [pubmed] PHST- 2014/08/20 06:00 [medline] AID - S0022-202X(15)36869-X [pii] AID - 10.1038/jid.2014.93 [doi] PST - ppublish SO - J Invest Dermatol. 2014 Jul;134(7):1951-1960. doi: 10.1038/jid.2014.93. Epub 2014 Feb 14.